GLY-201

N/A

Report date: 2023/07/14 17:58:57
NME

Base Information

Drug NameGLY-201
Drug Alias NameGLY-201
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionHigh Mobility Group Protein B1 inhibitors
TargetsHigh Mobility Group Protein B1
Therapy Area/IndicationsLiver Failure, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlycan Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesGlycan Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsLiver Failure, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A